↧
Image may be NSFW.
Clik here to view.
Clik here to view.
No Preemption No Problem: State Courts Step Up
For anyone following the U.S. Supreme Court’s emerging case law on FDA approval and preemption (as we have been here, here, here, and here), it looks like the next frontier is going to be state law....
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Pharma / Biotech R&D Budgets – A Proposal For Measuring Performance
During the BioFinance 2011 conference held in Toronto last week, one presenter showed a slide that outlined the number of new chemical entities (NCEs) approved by the FDA over a number of years. Since...
View Article